FDA approves first-ever mRNA flu vaccine for millions of older Americans

The FDA approved an mRNA flu vaccine for adults aged 60 and older. A clinical trial showed the vaccine reduced flu cases by 27% compared to a standard flu vaccine. The vaccine's development included an earlier regulatory review before final approval was granted.

Next story